Position in NVS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$608,097
+$81,986 QoQ
Shares Held
3,981
+4.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RiverFront Investment Group, LLC holds $89,602,289 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
32,968 | $39,542,811 | |
| 2 | JNJ |
Johnson & Johnson
|
64,265 | $16,321,382 | |
| 3 | ABBV |
AbbVie Inc.
|
59,624 | $15,003,783 | |
| 4 | MRK |
Merck & Co., Inc.
|
77,843 | $10,002,825 | |
| 5 | AMGN |
Amgen Inc
|
13,012 | $4,711,905 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
32,862 | $1,893,508 | |
| 7 | PFE |
Pfizer Inc
|
45,974 | $1,107,053 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,103 | $644,713 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $608,097 | 3,981 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $526,111 | 3,816 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $487,055 | 3,798 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $480,409 | 3,970 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $442,575 | 3,970 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||